You're right in that we're seeing a lot of condition-specific global partnerships. I think with the development of NHCC, and with these various neurological conditions coming together, it's made us realize, even more so, and now that we're about four years in, that the commonalities between these conditions are so similar.
Now we are getting the results from the study and we're starting to move into the synthesis. I think over the next couple of months we'll have a better idea of, obviously, what the findings are, what some of the gaps are, and what some of the opportunities are for research further down the road.
I think it's absolutely our aspiration that we would keep it at a level of the commonality between the neurological diseases, at the same time recognizing that condition-specific is absolutely needed.